Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
J Pediatr ; 227: 170-175, 2020 12.
Article in English | MEDLINE | ID: mdl-32622673

ABSTRACT

OBJECTIVE: To examine levels of plasma osteopontin (OPN), a recently described neuroinflammatory biomarker, in children with abusive head trauma (AHT) compared with children with other types of traumatic brain injury (TBI). STUDY DESIGN: The study cohort comprised children aged <4 years diagnosed with TBI and seen in the intensive care unit in a tertiary children's hospital. Patients were classified as having confirmed or suspected AHT or TBI by other mechanisms (eg, motor vehicle accidents), as identified by a Child Protection Team clinician. Serial blood samples were collected at admission and at 24, 48, and 72 hours after admission. Levels of OPN were compared across groups. RESULTS: Of 77 patients identified, 24 had confirmed AHT, 12 had suspected AHT, and 41 had TBI. There were no differences in the Glasgow Coma Scale score between the patients with confirmed AHT and those with suspected AHT and those with TBI (median score, 4.5 vs 4 and 7; P = .39). At admission to the emergency department, OPN levels were significantly higher in children with confirmed AHT compared with the other 2 groups (mean confirmed AHT, 471.5 ng/mL; median suspected AHT, 322.3 ng/mL; mean TBI, 278.0 ng/mL; P = .03). Furthermore, the adjusted mean trajectory levels of OPN were significantly higher in the confirmed AHT group compared with the other 2 groups across all subsequent time points (P = <.01). CONCLUSIONS: OPN is significantly elevated in children with confirmed AHT compared with those with suspected AHT and those with other types of TBI. OPN expression may help identify children with suspected AHT to aid resource stratification and triage of appropriate interventions for children who are potential victims of abuse.


Subject(s)
Brain Injuries, Traumatic/blood , Child Abuse , Craniocerebral Trauma/blood , Osteopontin/blood , Brain Injuries, Traumatic/diagnosis , Brain Injuries, Traumatic/metabolism , Child Abuse/diagnosis , Child, Preschool , Craniocerebral Trauma/diagnosis , Craniocerebral Trauma/metabolism , Female , Humans , Infant , Male , Osteopontin/biosynthesis , Prospective Studies
2.
J Neurooncol ; 134(1): 97-105, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28540667

ABSTRACT

The goal of this study was to investigate the impact of patient-, disease-, and treatment-related variables upon neurocognitive outcomes in pediatric patients with craniopharyngioma prior to treatment with proton therapy or observation after radical resection. For all participants (N = 104), relevant clinical and demographic variables were attained and neurocognitive evaluations completed prior to irradiation or planned observation. One-sample t-tests were conducted to compare performance to published normative data. Linear models were used to investigate predictors of performance on measures where performance was below normative expectations. Participants showed poorer performance in comparison to the normative group across neurocognitive domains including executive functions (e.g., working memory; Wechsler Digit Span Backward p = 0.03), learning and memory (e.g., California Verbal Learning Test [CVLT] Total T p = 0.00), and fine-motor coordination (e.g., Grooved Pegboard Dominant Hand p = 0.00). Poor performance across areas was predicted by presurgical hypothalamic involvement (e.g., Behavior Rating Inventory of Executive Function Working Memory Index Grade 2 ß = -7.68, p = 0.03; CVLT Total T Grade 2 ß = 7.94, p = 0.04; Grade 3 ß = -9.80, p = 0.00), extent of surgery (e.g., CVLT Total T Resection ß = -7.77, p = 0.04; Grooved Pegboard Dominant Hand ß = -1.58, p = 0.04), and vision status (e.g., CVLT Total T Reduced vision without impairment ß = -10.01, p = 0.02; Grooved Pegboard Dominant Hand Bilateral field defect ß = -1.45, p = 0.01; Reduced vision without impairment ß = -2.30, p = 0.00). This study demonstrated that patients with craniopharyngioma show weaker neurocognitive performance in comparison to the normative population resulting from tumor, events leading to diagnosis, and early surgical intervention. Systematic investigation of neurocognitive performance before treatment with radiation therapy is essential to evaluating the potential risks and benefits of newer methods of radiation therapy including proton therapy.


Subject(s)
Brain Neoplasms/complications , Brain Neoplasms/radiotherapy , Cognition Disorders/etiology , Craniopharyngioma/complications , Craniopharyngioma/radiotherapy , Proton Therapy , Adolescent , Brain Neoplasms/therapy , Child , Child, Preschool , Cohort Studies , Executive Function , Female , Humans , Infant , Infant, Newborn , Intelligence Tests , Learning , Linear Models , Male , Memory, Short-Term , Neuropsychological Tests , Perceptual Disorders/etiology , Ventriculostomy , Visual Perception/physiology , Young Adult
3.
Epilepsy Behav ; 52(Pt A): 260-3, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26492104

ABSTRACT

Jeavons syndrome (JS, eyelid myoclonia with absences [EMA]) consists of a triad of symptoms including eyelid myoclonia that may be accompanied by absence seizures, eye closure-induced EEG paroxysms or seizures, and photosensitivity. The age of onset ranges between 2 and 14 years with symptoms peaking between 6 and 8 years of age. Though investigation of the clinical, EEG, and neurological features of JS has occurred, neurocognitive functioning has not been well-delineated despite suggestion that a subtype of the syndrome is characterized in part by cognitive impairment. The purpose of this study was to define neurocognitive functioning in a more detailed manner by examining global IQ and relevant neurocognitive domains (i.e., verbal and nonverbal reasoning, attention, executive functioning, memory) in pediatric patients. The sample (N=6, 4 females) ranged in age from 8 to 15 years (M=11, SD=2.82). All participants completed neuropsychological evaluations. Statistical analyses revealed performance that was below average on measures of global IQ, processing speed and rote, verbal learning coupled with average nonverbal reasoning, and sustained attention. There was also evidence of impaired higher-level verbal reasoning. While global IQ ranged from low average to borderline impaired, no participant could be accurately described as impaired or having intellectual disability (ID) given the consistently average performance noted on some higher-order tasks including nonverbal reasoning.


Subject(s)
Cognition Disorders/psychology , Epilepsy, Absence/psychology , Myoclonus/psychology , Adolescent , Age of Onset , Attention , Child , Child, Preschool , Cognition Disorders/etiology , Electroencephalography , Executive Function , Female , Humans , Intelligence Tests , Learning , Male , Memory , Mental Processes , Neuropsychological Tests , Syndrome , Wechsler Scales
4.
Appl Neuropsychol Child ; : 1-9, 2023 Apr 28.
Article in English | MEDLINE | ID: mdl-37116100

ABSTRACT

Early neurobehavioral outcomes among infants with abusive head trauma (AHT) have not been well characterized. Though there are standardized measures for assessing infants, the ability of these measures to detect deficits may be limited. The Neonatal Intensive Care Unit (NICU) Network Neurobehavioral Scale, Second Edition (NNNS-II) has been correlated with neurobehavioral outcomes as early as birth but has not been used with this clinical group. There is no strong evidence of the concurrent validity of this measure. The primary goal was to examine the concurrent validity of the NNNS-II in patients with suspected AHT by comparing it to the Mullen Scales of Early Learning, American Guidance Service (AGS) Edition (Mullen). A secondary goal was to characterize early neurobehavioral outcomes among infants with suspected AHT across two measures. This retrospective study included 11 infants who sustained a traumatic brain injury (TBI) around 40 days of age. The sample's performance was variable and ranged from average to below average across measures. Participants experienced the most difficulty with visuospatial processing, attentional abilities, physiologic regulation, and asymmetric reflexes, and data suggested the NNNS-II may be more sensitive to deficits. There was evidence of concurrent validity of the NNNS-II based on strong to moderate correlations with the Mullen. Use of the NNNS-II shortly after the injury is more likely to showcase deficits, which may increase the likelihood that patients receive early intervention. Establishing concurrent validity of the NNNS-II further contributes to the evidence base regarding its criterion related validity, which may promote its more regular use.

5.
Clin Neuropsychol ; 34(7-8): 1380-1394, 2020.
Article in English | MEDLINE | ID: mdl-32847476

ABSTRACT

Objective: To describe the challenges related to COVID-19 affecting pediatric neuropsychologists practicing in inpatient brain injury rehabilitation settings, and offer solutions focused on face-to-face care and telehealth.Methods: A group of pediatric neuropsychologists from 12 pediatric rehabilitation units in North America and 2 in South America have met regularly since COVID-19 stay-at-home orders were initiated in many parts of the world. This group discussed challenges to clinical care and collaboratively problem-solvedsolutions.Results: Three primary challenges to usual care were identified, these include difficulty providing 1) neurobehavioral and cognitive assessments; 2) psychoeducation for caregivers and rapport building; and 3) return to academic instruction and home. Solutions during the pandemic for the first two areas focus on the varying service provision models that include 1) face-to-face care with personal protective equipment (PPE) and social distancing and 2) provision of care via remote methods, with a focus on telehealth. During the pandemic,neuropsychologists generally combine components of both the face-to-face and remote care models. Solutions to the final challenge focus on issues specific to returning to academic instruction and home after an inpatient stay.Conclusions: By considering components of in-person and telehealth models of patient care during the pandemic, neuropsychologists successfully serve patients within the rehabilitation setting, as well as the patient's family who may be limited in their ability to be physically present due to childcare, illness, work-related demands, or hospital restrictions.


Subject(s)
Betacoronavirus , Coronavirus Infections/therapy , Neurodevelopmental Disorders/rehabilitation , Neuropsychology/trends , Pandemics , Pneumonia, Viral/therapy , Telemedicine/trends , COVID-19 , Child , Coronavirus Infections/epidemiology , Female , Humans , Inpatients/psychology , Male , Neurodevelopmental Disorders/epidemiology , Neurodevelopmental Disorders/psychology , Neuropsychological Tests , Neuropsychology/methods , Pneumonia, Viral/epidemiology , SARS-CoV-2 , Telemedicine/methods
6.
Appl Neuropsychol Child ; 8(2): 113-122, 2019.
Article in English | MEDLINE | ID: mdl-29161113

ABSTRACT

Cogmed is a computerized cognitive intervention utilizing coaches who receive standardized instruction in analyzing training indices and tailoring feedback to remotely monitor participant's performance. The goal of this study was to examine adherence, satisfaction, and efficacy of Cogmed across coaches. Survivors of pediatric brain tumors and acute lymphoblastic leukemia (N = 68) were randomized to intervention (Cogmed) or waitlist control. The intervention group was matched with one of two coaches. Cognitive assessments were completed before and after intervention, and participants and caregivers in the intervention group completed satisfaction surveys. T-tests showed no differences in adherence across coaches (number of sessions completed p = .38; d = .32). Noninferiority statistics were not consistently equivalent for satisfaction, but equivalence was supported for caregiver perceptions of pragmatic utility and participant perceptions of logistical ease of Cogmed. Equivalence was not consistently suggested for cognitive outcomes, but was supported on measures tapping relevant cognitive domains (attention, working memory, processing speed, academic fluency). This study suggests adherence can be maintained across coaches. While aspects of satisfaction and cognitive outcomes were equivalent, the possible influence of coach-based variables cannot be ruled out. Findings highlight challenges in standardizing the coaching component of multicomponent computerized interventions and the need for ongoing research to establish dessiminability.


Subject(s)
Brain Neoplasms/rehabilitation , Cancer Survivors , Cognitive Dysfunction/rehabilitation , Cognitive Remediation/methods , Health Personnel , Memory, Short-Term/physiology , Outcome and Process Assessment, Health Care , Precursor Cell Lymphoblastic Leukemia-Lymphoma/rehabilitation , Therapy, Computer-Assisted/methods , Treatment Adherence and Compliance , Adolescent , Brain Neoplasms/complications , Child , Cognitive Dysfunction/etiology , Female , Humans , Male , Patient Satisfaction , Precursor Cell Lymphoblastic Leukemia-Lymphoma/complications
SELECTION OF CITATIONS
SEARCH DETAIL